Bank of New York Mellon’s Bolt Biotherapeutics BOLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-629
| Closed | -$16.1K | – | 4341 |
|
|
2023
Q2 | $16.1K | Sell |
629
-2
| -0.3% | -$51 | ﹤0.01% | 4298 |
|
|
2023
Q1 | $17.6K | Hold |
631
| – | – | ﹤0.01% | 4314 |
|
|
2022
Q4 | $16.4K | Sell |
631
-3
| -0.5% | -$78 | ﹤0.01% | 4373 |
|
|
2022
Q3 | $19K | Sell |
634
-9
| -1% | -$270 | ﹤0.01% | 4453 |
|
|
2022
Q2 | $26K | Sell |
643
-3,922
| -86% | -$159K | ﹤0.01% | 4462 |
|
|
2022
Q1 | $249K | Buy |
4,565
+524
| +13% | +$28.6K | ﹤0.01% | 4117 |
|
|
2021
Q4 | $397K | Buy |
4,041
+511
| +14% | +$50.2K | ﹤0.01% | 3941 |
|
|
2021
Q3 | $893K | Buy |
3,530
+1,199
| +51% | +$303K | ﹤0.01% | 3447 |
|
|
2021
Q2 | $721K | Buy |
2,331
+727
| +45% | +$225K | ﹤0.01% | 3592 |
|
|
2021
Q1 | $1.06M | Buy |
+1,604
| New | +$1.06M | ﹤0.01% | 3299 |
|